This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Elizabeth B. Rappaport, MD; Daniel Fife, MD

Am J Dis Child. 1985;139(4):396-399.

Abstract
• Slipped capital femoral epiphysis (SCFE), a potentially disabling hip disorder, occurs primarily during the pubertal growth spurt. It has been reported in association with pituitary gigantism, growth hormone deficiency, hypothyroidism, hypogonadism, and panhypopituitarism. We estimated the frequency of SCFE among children with growth hormone deficiency (treated or untreated) and compared it with the reported frequency of SCFE among Connecticut residents under 25 years of age. Based on this comparison, the risk of developing SCFE is significantly greater in growth hormone–deficient children than in the general population.

(AJDC 1985;139:396-399)

Author Affiliations
From the Division of Metabolism and Endocrine Drug Products, Food and Drug Administration, Rockville, Md (Dr Rappaport), and the Insurance Institute for Highway Safety, Washington, DC (Dr Fife).

Footnotes
Reprint requests to Division of Metabolism and Endocrine Products, HFN-810, Center for Drugs and Biologics, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857 (Dr Rappaport).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-Term Safety of Recombinant Human Growth Hormone in Turner Syndrome
Bolar et al.
J. Clin. Endocrinol. Metab. 2008;93:344-351.
ABSTRACT | FULL TEXT  

Optimizing GH Therapy in Adults and Children
Drake et al.
Endocr. Rev. 2001;22:425-450.
ABSTRACT | FULL TEXT